The Delhi High Court Division Bench set aside an injunction against Natco Pharma in the Novartis Eltrombopag patent dispute. The judgment provides key guidance on patent validity challenges and the requirements under Section 3(d) of the Patents Act in pharmaceutical cases.
Read more about Cancerous Battle: Novartis and NATCO clash over EltrombopagTag: India Patent Law
Profiting from the Patent Cliff: What Drug Manufacturers Need to Know about Secondary Patents
This post explores how drug manufacturers leverage secondary patents to manage the patent cliff and maintain exclusivity. A detailed analysis of Entresto’s patent timeline and Indian legal context is provided.
Read more about Profiting from the Patent Cliff: What Drug Manufacturers Need to Know about Secondary PatentsPatents (Amendment) Rules, 2020, LDC’s request WTO to extend transition period and more
The Patents Amendment Rules 2020 have come into effect in India, bringing notable changes to patent filing and reporting requirements. This bulletin covers updates on patent disputes, TRIPS transition requests at the WTO, and international patent office collaborations. The content is compiled to inform stakeholders about crucial developments in patent law.
Read more about Patents (Amendment) Rules, 2020, LDC’s request WTO to extend transition period and moreFree Patent Filings for Open COVID Pledge Adopters
BananaIP is offering free patent and design filings in India for eligible COVID-19 related inventions if applicants adopt the Open COVID Pledge. This initiative aims to encourage innovation and open access to intellectual property in the fight against COVID-19.
Read more about Free Patent Filings for Open COVID Pledge AdoptersUNDP Issues Guidelines For Pharmaceutical Patent Examination
The UNDP has issued new guidelines aimed at strengthening pharmaceutical patent examination with an emphasis on public health. The guidelines advocate for stricter standards and the use of TRIPS flexibilities to curb evergreening and improve access to medicines.
Read more about UNDP Issues Guidelines For Pharmaceutical Patent ExaminationThe Case of Indian Intellectual Property – Misplaced Perception
This article analyses how Indian intellectual property is perceived internationally, especially by the United States, and assesses India’s progress over the past decade. It highlights the importance of understanding India’s unique legal and policy framework for intellectual property.
Read more about The Case of Indian Intellectual Property – Misplaced PerceptionXiaomi maintains competitive pricing; Removes onus of Royalties on customers
Xiaomi faces a patent dispute in India but continues to offer competitively priced smartphones. The company leverages its agreements with Qualcomm and focuses on risk mitigation while maintaining its commitment to Indian customers.
Read more about Xiaomi maintains competitive pricing; Removes onus of Royalties on customers